Author

M. Yazdimamaghani

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1

Frequent Co-Authors

A. Kabanov· 2 shared C. Lim· 2 shared D. Hwang· 2 shared C. M. Perou· 1 shared C. Perou· 1 shared H. Hyun· 1 shared H. M. Atkins· 1 shared J. D. Ramsey· 1 shared

Activity by Year

2022-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

A. Kabanov

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Tumor microenvironment immunomodulation by nanoformulated TLR 7/8 agonist and PI3k delta inhibitor enhances therapeutic benefits of radiotherapy

M. Yazdimamaghani, O. Kolupaev, C. Lim, D. Hwang, S. Laurie, C. Perou, A. Kabanov, J. Serody

This study shows that combining nanoformulated TLR7/8 agonist and PI3K delta inhibitor with radiotherapy improves anti-tumor activity in TNBC by modulating the tumor microenvironment.

bioRxiv · Mar 9, 2024Immunology

High-Dose Paclitaxel and its Combination with CSF1R Inhibitor in Polymeric Micelles for Chemoimmunotherapy of Triple Negative Breast Cancer

C. Lim, D. Hwang, M. Yazdimamaghani, H. M. Atkins, H. Hyun, Y. Shin, J. D. Ramsey, C. M. Perou, M. Sokolsky-Papkov, A. Kabanov

This study evaluates high-dose paclitaxel and its combination with CSF1R inhibitor in polymeric micelles for chemoimmunotherapy of triple-negative breast cancer, showing improved therapeutic outcomes and immune response.

bioRxiv · Aug 12, 2022Cancer Biology